![]() |
Merrimack announces results from MM-302 Phase I trial on advanced HER2 positive breas
Merrimack Pharmaceuticals, Inc. today announced Phase I clinical trial results for MM-302, the company's novel agent for the treatment of advanced HER2 positive (HER2+ or ErbB2+) breast cancer.
More... |
Re: Merrimack announces results from MM-302 Phase I trial on advanced HER2 positive b
I was on this study. Didn't work for me, which was a bummer for many reasons, but not least of all because it was very easy to tolerate! And it did work for a lot of folks. Could be a great new weapon for the arsenals.
|
| All times are GMT -7. The time now is 03:47 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021